Latest KFF Health News Stories
New Rules Try To Shore Up Individual Health Insurance Market In 2018
The Trump administration’s first health regulation would shorten the enrollment periods and make it harder for patients to get coverage outside of that annual signup period.
Individual Insurance Primer: Long-Troubled Market At Center Of Drive For Repeal
People who do not get insurance through their job or the government have long battled a difficult market.
Docs Bill Medicare For End-Of-Life Advice As ‘Death Panel’ Fears Reemerge
The federal program paid $16 million in the first six months of 2016 to counsel 223,000 patients about treatment preferences in their last days.
Influence Of GOP Doctors Caucus Grows As Congress Looks To Replace Health Law
As conservative physicians rise to more powerful positions in government, some question whether they speak for the nation’s doctors.
A Deep Dive Into 4 GOP Talking Points On Health Care
The president says Obamacare has been “a complete and total disaster,” and other Republicans see nothing but trouble. But a careful look at the arguments suggest the situation is more complicated.
Former FDA Chief Cites 5 Things To Watch On Drug Approvals And Keeping Drugs Safe
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
Judge Upends Effort To Limit Charity Funding For Kidney Patients’ Insurance
A federal judge in Texas last month issued a preliminary injunction barring the government from enforcing a rule allowing insurers to refuse to insure dialysis patients who get premium assistance from charity groups.
Drugmaker Marathon ‘Pausing’ Delivery Of $89,000-A-Year Muscular Dystrophy Drug
After hearing complaints about its high price, Marathon Pharmaceuticals is pausing the launch of an $89,000 drug for a rare disease.
¿Cómo superar el miedo a la muerte? Trata con el amor
Cada uno debe encontrar su propia manera de manejar el miedo a la muerte. Una experta, quien superó su propio miedo a través de años de asistir a los moribundos, dice que la muerte raramente es tan terrible como la mayoría de la gente teme.
Death Doesn’t Have To Be So Scary
Taking time to discuss the inevitable can help conquer a universal fear.
California Reports Thousands Of Workers Exposed To Elevated Lead Levels
More than 6,000 workers had levels in their blood that could lead to heart, kidney or cognitive disease, according to state findings.
Obamacare Came To Montana Indian Country And Brought Jobs
In remote parts of Montana, the Affordable Care Act has meant better health care for Native Americans and more job opportunities.
California Regulator Slams Health Insurers Over Faulty Doctor Lists
A new report finds that major insurers like Aetna and UnitedHealth submitted conflicting lists to the state that were off by thousands of doctors.
El secretario de Salud Tom Price podría cambiar rápido 5 temas clave de salud
La planificación familiar, Planned Parenthood y hasta el consumo de tabaco podrían verse rápidamente afectados por medidas que podría tomar el flamante secretario de Salud.
Grassley Launches Inquiry Into Orphan Drugs After KHN Investigation
Citing a Kaiser Health News investigation, Senate Judiciary Committee Chairman Chuck Grassley vows to examine the orphan drug program and possible fixes.
What Made Obamacare Succeed In Some States? Hint: It’s Not Politics
A study of five states looks at the market conditions that make or break the health insurance marketplaces set up by the Affordable Care Act.
Five Quick Ways HHS Secretary Tom Price Could Change The Course Of Health Policy
After a tough fight by Democrats, Senate Republicans confirmed Rep. Tom Price’s nomination to head the Department of Health and Human Services. He will have the authority to upend some current practices.
Despite Prevention Guidelines, Few Smokers Seek CT Scans To Check For Lung Cancer
Lung cancer screening rates have not changed much even though the U.S. Preventive Services Task Force has recommended that smokers get checked, according to a new study.
Dozens Of New Cancer Drugs Do Little To Improve Survival, Frustrating Patients
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
‘Massive Confusion’ Abounds For Insurers As GOP Wavers On Obamacare Redo
Republicans’ delay in finding common ground to repeal and replace the health law raises risks that coverage could shrink and rates rise even more, the industry says.
